Meb

Meb is a Chinese digital health and medical aesthetics platform focused on online consultation, provider discovery, appointment booking, and peri-procedural support for cosmetic and aesthetic medical services. The company operates the Meb website and app, connecting consumers with hospitals and physicians across China for services spanning injectables, surgery, skin treatments, hair restoration, and dental aesthetics. Rather than developing therapeutics, Meb functions as a third-party service and marketplace platform with consultation, matching, care-navigation, and post-procedure support capabilities. Publicly available sources indicate nationwide coverage in China, substantial traffic and consultation volume, and multiple venture financing rounds, including a reported RMB 100 million Series B round. For a biotech analyst, this is best understood as a commercial consumer-facing healthcare services and medical-aesthetics internet company, not a drug developer.